A-68930, a novel, potent dopamine D1 receptor agonist: a microstructural analysis of its effects on feeding and other
1Laboratory of Psychopharmacology, School of Psychology, University of Birmingham, Birmingham B15 2TT, UK.
Abstract:
A-68930 [1R, 3S)-1-aminomethyl-5,6-dihydroxy-3-phenylisochroman HCI] is a novel, potent and selective dopamine D1 receptor agonist. Previous reports have shown that the selective D1 partial agonist, SK & F 38393, reduced food consumption in rats and mice. The aim of this study was to undertake a microstructural analysis of the effects of A-68930 on food intake and feeding behaviour in non-deprived male rats trained to consume a highly palatable diet in a 20min period. A-68930 (0.1-1.0mg/kg, s.c.) produced a dose-dependent reduction in food intake which was due to a reduction in the frequency of bouts of feeding but not to a reduction in bout duration. A-68930 had little effect on the latency to initiate feeding or on the local rate of eating. Hence, it had a selective action on the parameters of eating, which is distinctly different from the effects of selective D2 agonists or of indirectly acting psychomotor stimulants like cocaine. A-68930 also increased grooming by lengthening the grooming bouts, and reduced locomotion and rearing responses. At the largest dose, immobility was increased. The anorectic effect of A-68930 may reflect, at least in part, the increased grooming it produces.
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...


